Fig. 6From: Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor modelAutoradiography (a), fluorescence imaging (b), and immunohistochemistry (hematoxylin and eosin (c) and HER2 (d)) of 5-μm paraffin-embedded breast tumor sections confirmed fluorescence and radioactive signals co-localized with HER2-expressing tumorsBack to article page